通过下一代测序识别了五种新的HLA-B静音变体
Maria Loginova1,2, Julia Dudina1, Igor Paramonov1
1Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute Under the Federal Medicine and Biology Agency, Kirov, Russia.
HLA
|April 24, 2025
概括
研究人员使用下一代测序发现了五种新的人类白细胞抗原-B (HLA-B) 沉默变异. 这些新的HLA-B变异扩大了我们对HLA-B遗传多样性的理解.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
- 人类遗传学 人类遗传学
背景情况:
- 人类白细胞抗原-B (HLA-B) 基因是免疫系统的关键组成部分.
- 在HLA-B中的遗传变异会影响免疫反应和疾病易感性.
- 识别新型HLA-B变异对于了解种群遗传学和移植兼容性至关重要.
研究的目的:
- 报告在HLA-B基因中发现了新的无声变异.
- 在一个关键的免疫系统基因中表征新的遗传变异.
主要方法:
- 下一代测序 (NGS) 用于高通量遗传分析.
- 生物信息工具被用来识别和描述序列变异.
主要成果:
- 鉴定出了HLA-B基因的五种以前未报告的沉默变异.
- 这些新型变种被指定为HLA-B*08:01:81,HLA-B*18:01:59,HLA-B*35:01:82,HLA-B*35:03:45,以及HLA-B*51:17:02.这些新型变种的名称分别为HLA-B*08:01:81,HLA-B*18:01:59,HLA-B*35:01:82,HLA-B*35:03:45,以及HLA-B*51:17:02.
- 这些变异在HLA-B位点内代表了新的等位基形式.
结论:
- 这五种新型HLA-B无声变异的发现为人类遗传多样性的全面目录做出了贡献.
- 这些发现提高了HLA类型的分辨率,并可能对人口遗传学和个性化医学产生影响.
相关概念视频
Next-generation Sequencing
86.1K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
86.1K
Genome-wide Association Studies-GWAS
12.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.1K


